We’re heading to #SITC25 (Nov 5–9, Gaylord National Resort). Visit @cdi_labs at Booth 515 to see how our tech is redefining #autoimmunity and #immunotherapy research, and how we can help advance your research.

Excited to join #DiscoveryOnTarget in Boston to explore the latest in drug discovery.Interested in finding out more about how @CDILabs is advancing in membrane protein & GPCR research? Let’s connect. #DrugDiscovery #GPCR #MembraneProteins #CDI

As #DiscoveryOnTarget wraps up, CDI Labs appreciates the chance to contribute to discussions on antibody validation and research reproducibility. Didn’t connect at the event? Reach us at info@cdilabs.com to continue the conversation. #LifeSciences #AntibodyValidation

We’re proud that our very own Erik Johansen, R&D Applications Scientist, speaks today at 2:30 PM at #DiscoveryOnTarget. Hear about “VirD Microarrays for Native GPCR Analysis & Antibody Screening”—join his session and connect with CDI! #GPCR #DrugDiscovery

In a recent paper published in Frontiers in Immunology, Dr. Ying Ye and colleagues at the Chongqing Medical University revealed down-regulated autoantibodies in early lung cancer patients. These tumor-associated autoantibodies can be detected months to years before diagnosis,

Next week, we're in beautiful Vienna, Austria, for the #IUIS2025 conference! Join us at Booth 64 to discover how CDI Labs is revolutionizing immunology research with our cutting-edge technologies and unparalleled lab services. We're dedicated to advancing research in immunology,

We’re excited to celebrate (and maybe brag a little) about our impact on advancing research and empowering scientists to publish their groundbreaking studies in some of the world's most prestigious journals. With over 350+ high-profile papers citing our cutting-edge platforms and

PRESS RELEASE: We’re excited to announce the launch of our comprehensive Pan-isotype Profiling and Analysis platform! This cutting-edge solution enables researchers to explore all isotypes and subclasses, including IgA, IgD, IgE, IgG, and IgM, providing deeper insights into

Decode murine autoantibodies like never before – profile over 50,000+ proteins from the entire mouse proteome in ONE assay. Our #MouseScan™ PhIP-Seq (Phage Display ImmunoPrecipitation Sequencing) platform enables researchers to uncover epitope-level insights into immune

In a paper published in Frontiers in Immunology, Lixin Zhang and colleagues at the University of Pittsburgh School of Medicine explore the complex role of B lymphocytes in the ovarian tumor microenvironment. Utilizing #HuProt's cutting-edge human proteome microarray, the

^^^ if you’d like to work on this we just built a pan-human peptide hormone PhIP-Seq library to find these @cdi_labs - surprise - “healthy” people have autoabs to satiation hormones. Bring a cohort and a plan for validation assays and let’s get to it.

PRESS RELEASE: We are thrilled to announce the launch of our innovative Peptide Hormone PhIP-Seq library, a groundbreaking advancement in identifying hormone-specific autoantibodies. This cutting-edge technology combines phage display with next-gen sequencing, enabling

In this insightful blog by Shaohui Hu, Wendy Yap and Shuang Liu, we explore the history and innovation of #HuProt™, the world’s largest, most comprehensive protein microarray. Representing over 81% of the human proteome, HuProt revolutionizes the study of protein functions and

Unlock the secrets of the human immune system with #VirScan® PHIP-Seq, the cutting-edge platform revolutionizing pathogen detection and immune profiling. Powered by Phage Display ImmunoPrecipitation Sequencing (PHIP-Seq), VirScan takes immune analysis to the next level. By

CDI Labs at #FOCIS2025! Join us tomorrow, June 26, at 7:30 PM (Poster # Th189), for an exciting poster session titled, "Seromic Atlas of APS-1 Syndrome." Presented by Tyler Hulett, PhD, this session will delve into groundbreaking advances in the use of synthetic biology tools for